MENU
+Compare
CERS
Stock ticker: NASDAQ
AS OF
Sep 16 closing price
Price
$1.26
Change
+$0.06 (+5.00%)
Capitalization
241.54M

CERS Cerus Corp Forecast, Technical & Fundamental Analysis

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety... Show more

CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CERS with price predictions
Sep 16, 2025

Momentum Indicator for CERS turns negative, indicating new downward trend

CERS saw its Momentum Indicator move below the 0 level on September 10, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 110 similar instances where the indicator turned negative. In of the 110 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CERS turned negative on September 10, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CERS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CERS entered a downward trend on August 27, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where CERS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CERS advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .

CERS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.357) is normal, around the industry mean (60.170). P/E Ratio (0.000) is within average values for comparable stocks, (38.085). CERS's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.614). CERS has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (1.227) is also within normal values, averaging (128.106).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CERS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CERS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
CERS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CERS is expected to report earnings to fall 11.00% to -2 cents per share on October 30

Cerus Corp CERS Stock Earnings Reports
Q3'25
Est.
$-0.03
Q2'25
Est.
$-0.03
Q1'25
Est.
$-0.04
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.01
The last earnings report on August 05 showed earnings per share of -2 cents, meeting the estimate of -2 cents. With 945.97K shares outstanding, the current market capitalization sits at 241.54M.
A.I. Advisor
published General Information

General Information

a developer of the INTERCEPT Blood System for platelets and plasma

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
1220 Concord Avenue
Phone
+1 925 288-6000
Employees
288
Web
https://www.cerus.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ROHCY14.590.51
+3.62%
Rohm Co. Ltd.
NTDTY27.280.29
+1.06%
NTT DATA GROUP CORPORATION
LRCDF24.340.22
+0.91%
Laurentian Bank of Canada
NVAAF0.20N/A
N/A
Nova Minerals Ltd.
AMFL0.10-0.01
-6.91%
American Films, Inc.

CERS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CERS has been loosely correlated with ITGR. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then ITGR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
+5.00%
ITGR - CERS
49%
Loosely correlated
+2.87%
CLPT - CERS
48%
Loosely correlated
+1.72%
LAB - CERS
47%
Loosely correlated
+0.73%
ICUI - CERS
46%
Loosely correlated
-1.37%
SGHT - CERS
46%
Loosely correlated
-0.85%
More

Groups containing CERS

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERS
1D Price
Change %
CERS100%
+5.00%
Medical/Nursing Services
industry (225 stocks)
55%
Loosely correlated
+0.33%
Health Services
industry (437 stocks)
36%
Loosely correlated
+0.46%